Furthermore, we evaluated the efficacy of the PAK4‐targeted proteolysis‐targeting chimera (PROTAC) SJ‐05, which induces selective protein degradation [17], and examined PAK4 expression as well as its regulation of AMPK phosphorylation in human muscle tissues with sarcopenia. The gene discussed is PRKAA2; the disease is sarcopenia.